Cargando…
Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions
Carvedilol (Cav), a nonselective β-blocker with α1 adrenoceptor blocking effect, has been used as a standard therapy for coronary artery disease. This study investigated the effects of Cav on exosome expression and function, ATP-binding cassette transporter A1 (ABCA1) expression, and cholesterol eff...
Autores principales: | Chen, Sy-Jou, Tsui, Pi-Fen, Chuang, Yi-Ping, Chiang, Dapi Meng-Lin, Chen, Liv Weichien, Liu, Shu-Ting, Lin, Feng-Yen, Huang, Shih-Ming, Lin, Shih-Hua, Wu, Wan-Lin, Tsai, Min-Chien, Lin, Chin-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834197/ https://www.ncbi.nlm.nih.gov/pubmed/31635197 http://dx.doi.org/10.3390/ijms20205202 |
Ejemplares similares
-
Pitavastatin Exerts Potent Anti-Inflammatory and Immunomodulatory Effects via the Suppression of AP-1 Signal Transduction in Human T Cells
por: Chen, Liv Weichien, et al.
Publicado: (2019) -
Cholesterol efflux pathways, inflammation, and atherosclerosis
por: Groenen, Anouk G., et al.
Publicado: (2021) -
Spices and Atherosclerosis
por: Tsui, Pi-Fen, et al.
Publicado: (2018) -
MicroRNA-320b Modulates Cholesterol Efflux and Atherosclerosis
por: Lu, Xiaomei, et al.
Publicado: (2022) -
Photobiomodulation therapy promotes the ATP‐binding cassette transporter A1‐dependent cholesterol efflux in macrophage to ameliorate atherosclerosis
por: Yin, Qianxia, et al.
Publicado: (2021)